Lifang Ye

1.7k citations
92 papers · 1.3k indexed · h-index 21
Topics
Inflammatory Myopathies and Dermatomyositis (12 papers)Cardiovascular Function and Risk Factors (9 papers)Heart Failure Treatment and Management (7 papers)

In The Last Decade

Lifang Ye

85 papers receiving 1.2k citations

Peers

Lifang Ye
Comparison fields: 5 of 136
  • Molecular Biology 355
  • Epidemiology 303
  • Cardiology and Cardiovascular Medicine 197
  • Pulmonary and Respiratory Medicine 152
  • Rheumatology 136
Replace Ye Yan with:
Ye Yan China
Xi Chu China
Dan Liu China
Yafei Chen China
Wenwen Fu China
Wei Ding China
Chun Liang China
Xiance Sun China
Yanyan Liu China
Shin‐ya Morita Japan
Lifang Ye relative to Ye Yan China Ye Yan's profile →
Citations per field
00.5×3.0×
Ye Yan · 1×
Citations per year

Countries citing papers authored by Lifang Ye

Since Specialization
Citations

This map shows the geographic impact of Lifang Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifang Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifang Ye more than expected).

Fields of papers citing papers by Lifang Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifang Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifang Ye. The network helps show where Lifang Ye may publish in the future.

Co-authorship network of co-authors of Lifang Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Lifang Ye. A scholar is included among the top collaborators of Lifang Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifang Ye. Lifang Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 5
4 5
5 0
6 2
7 5
8 8
9 0
10 9
11 11
12 1
13 2
14 8
15
Wnt/β-Catenin Participates in the Repair of Acute Respiratory Distress Syndrome-Associated Early Pulmonary Fibrosis via Mesenchymal Stem Cell Microvesicles
11
16 32
17 5
18 1
19 39
20 15

About Lifang Ye

Lifang Ye is a scholar working on Sensory Systems, Complementary and alternative medicine and Cardiology and Cardiovascular Medicine, having authored 92 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (12 papers), Cardiovascular Function and Risk Factors (9 papers) and Heart Failure Treatment and Management (7 papers). The work is most often cited by research in Complementary and alternative medicine (95 citations), Sensory Systems (53 citations) and Pharmacology (86 citations). Lifang Ye has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lihong Wang, Wenbin Shang, Lihong Wang, Xizhong Yu, Guochun Wang, Qiqi Yan, Yu Zuo, Jianrong Li, Junli Zhu and Xiaoming Shu. Their work appears in journals such as PLoS ONE, Scientific Reports and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026